{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:49:32Z","timestamp":1791686972088,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R95-A1092"],"award-info":[{"award-number":["R95-A1092"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ejps.2018.04.014","type":"journal-article","created":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T21:52:18Z","timestamp":1523310738000},"page":"31-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["The use of molecular descriptors in the development of co-amorphous formulations"],"prefix":"10.1016","volume":"119","author":[{"given":"Helena","family":"Meng-Lund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Kasten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrine Tarp","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Poso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0369-2909","authenticated-orcid":false,"given":"Tatu","family":"Pantsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7521-6020","authenticated-orcid":false,"given":"Thomas","family":"Rades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8211-5607","authenticated-orcid":false,"given":"Jukka","family":"Rantanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0482-1397","authenticated-orcid":false,"given":"Holger","family":"Grohganz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2018.04.014_bb0005","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/mp500303a","article-title":"Computational predictions of glass-forming ability and crystallization tendency of drug molecules","volume":"11","author":"Alhalaweh","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.04.014_bb0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2009.01.027","article-title":"Enhanced dissolution rate and synchronized release of drugs in binary systems through formulation: amorphous naproxen\u2013cimetidine mixtures prepared by mechanical activation","volume":"136","author":"Alles\u00f8","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.04.014_bb0015","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1021\/ci5004834","article-title":"Experimental and computational prediction of glass transition temperature of drugs","volume":"54","author":"Alzghoul","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejps.2018.04.014_bb0020","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s11095-007-9394-1","article-title":"Indomethacin\u2013saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization","volume":"25","author":"Basavoju","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.04.014_bb0025","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1517\/17425255.1.4.613","article-title":"Computational models to predict aqueous drug solubility, permeability and intestinal absorption","volume":"1","author":"Bergstr\u00f6m","year":"2005","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejps.2018.04.014_bb0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.chemolab.2004.12.011","article-title":"Performance of some variable selection methods when multicollinearity is present","volume":"78","author":"Chong","year":"2005","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"10.1016\/j.ejps.2018.04.014_bb0035","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejps.2017.03.013","article-title":"Surface area, volume and shape descriptors as a novel tool for polymer lead design and discovery","volume":"102","author":"Christensen","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.04.014_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0166-1280(99)00360-7","article-title":"Molecular fields in quantitative structure\u2013permeation relationships: the VolSurf approach","volume":"503","author":"Cruciani","year":"2000","journal-title":"J. Mol. Struct."},{"issue":"Supplement 2","key":"10.1016\/j.ejps.2018.04.014_bb0045","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0928-0987(00)00162-7","article-title":"VolSurf: a new tool for the pharmacokinetic optimization of lead compounds","volume":"11","author":"Cruciani","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.04.014_bb0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejps.2014.05.015","article-title":"Preparation and characterization of co-amorphous ritonavir\u2013indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions","volume":"62","author":"Dengale","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.04.014_bb0055","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1039\/C5CC08216A","article-title":"Pharmaceutical cocrystals: along the path to improved medicines","volume":"52","author":"Duggirala","year":"2016","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejps.2018.04.014_bb0060","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijpharm.2012.11.028","article-title":"Use of pharmaceutical salts and cocrystals to address the issue of poor solubility","volume":"453","author":"Elder","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.04.014_bb0065","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijpharm.2013.04.032","article-title":"Coamorphous repaglinide\u2013saccharin with enhanced dissolution","volume":"450","author":"Gao","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.04.014_bb0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1021\/ar800001k","article-title":"Predicting hydrogen-bond strengths from acid\u2212base molecular properties. The pKa slide rule: toward the solution of a long-lasting problem","volume":"42","author":"Gilli","year":"2009","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejps.2018.04.014_bb0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ejps.2018.04.014_bb0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/10837450.2016.1163390","article-title":"Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan","volume":"22","author":"Huang","year":"2017","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2018.04.014_bb0085","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/jphp.12458","article-title":"Preparation and characterization of spray-dried co-amorphous drug\u2013amino acid salts","volume":"68","author":"Jensen","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2018.04.014_bb0090","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1021\/acs.molpharmaceut.5b00295","article-title":"Formation mechanism of Coamorphous drug-amino acid mixtures","volume":"12","author":"Jensen","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.04.014_bb0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejps.2016.08.022","article-title":"Development of a screening method for co-amorphous formulations of drugs and amino acids","volume":"95","author":"Kasten","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.04.014_bb0100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijpharm.2017.09.063","article-title":"Performance comparison between crystalline and co-amorphous salts of indomethacin-lysine","volume":"533","author":"Kasten","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.04.014_bb0105","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1021\/mp500107s","article-title":"Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability","volume":"11","author":"Laitinen","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.04.014_bb0110","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ejpb.2013.03.014","article-title":"Amino acids as co-amorphous stabilizers for poorly water soluble drugs - part 1: preparation, stability and dissolution enhancement","volume":"85","author":"Lobmann","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.04.014_bb0115","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1021\/mp2002973","article-title":"Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen","volume":"8","author":"Lobmann","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.04.014_bb0120","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ejpb.2013.03.026","article-title":"Amino acids as co-amorphous stabilizers for poorly water-soluble drugs - part 2: molecular interactions","volume":"85","author":"Lobmann","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.04.014_bb0125","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1021\/mp100339c","article-title":"Toward in silico prediction of glass-forming ability from molecular structure alone: a screening tool in early drug development","volume":"8","author":"Mahlin","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.04.014_bb0130","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijpharm.2011.10.046","article-title":"Cocrystallization and amorphization induced by drug\u2013excipient interaction improves the physical properties of acyclovir","volume":"422","author":"Masuda","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.04.014_bb0135","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1007\/s11095-006-9032-3","article-title":"Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API","volume":"23","author":"McNamara","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.04.014_bb0140","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijpharm.2017.03.043","article-title":"Correlation between calculated molecular descriptors of excipient amino acids and experimentally observed thermal stability of lysozyme","volume":"523","author":"Meng-Lund","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.04.014_bb0145","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1021\/mp400712m","article-title":"Phase separation in coamorphous systems: in silico prediction and the experimental challenge of detection","volume":"11","author":"Pajula","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.04.014_bb0150","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1021\/acs.cgd.5b00349","article-title":"Coamorphous lurasidone hydrochloride\u2013saccharin with charge-assisted hydrogen bonding interaction shows improved physical stability and enhanced dissolution with pH-independent solubility behavior","volume":"15","author":"Qian","year":"2015","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2018.04.014_bb0160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/B:PHAM.0000016237.06815.7a","article-title":"A quantitative structure-property relationship for predicting drug solubility in PEG 400\/water cosolvent systems","volume":"21","author":"Rytting","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.04.014_bb0165","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1021\/cg900129f","article-title":"Pharmaceutical cocrystals and their physicochemical properties","volume":"9","author":"Schultheiss","year":"2009","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2018.04.014_bb0170","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejmech.2013.11.045","article-title":"Pharmaceutical salts and cocrystals involving amino acids: a brief structural overview of the state-of-art","volume":"74","author":"Tilborg","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2018.04.014_bb0175","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s11095-015-1848-2","article-title":"A strategy for co-former selection to design stable co-amorphous formations based on physicochemical properties of non-steroidal inflammatory drugs","volume":"33","author":"Ueda","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.04.014_bb0180","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrd1032","article-title":"ADMET in silico modelling: towards prediction paradise?","volume":"2","author":"Van de Waterbeemd","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2018.04.014_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ddtec.2011.10.002","article-title":"The use of amorphous solid dispersions: a formulation strategy to overcome poor solubility and dissolution rate","volume":"9","author":"Van den Mooter","year":"2012","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejps.2018.04.014_bb0190","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1208\/s12249-015-0371-4","article-title":"Co-amorphous combination of nateglinide-metformin hydrochloride for dissolution enhancement","volume":"17","author":"Wairkar","year":"2016","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2018.04.014_bb0195","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1021\/ci990307l","article-title":"Prediction of physicochemical parameters by atomic contributions","volume":"39","author":"Wildman","year":"1999","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.ejps.2018.04.014_bb0200","series-title":"Chemometric Methods in Molecular Design","first-page":"213","article-title":"PLS for multivariate linear modeling","author":"Wold","year":"1995"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718301738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718301738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T16:46:46Z","timestamp":1571071606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098718301738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":39,"alternative-id":["S0928098718301738"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2018.04.014","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of molecular descriptors in the development of co-amorphous formulations","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2018.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}